Tankyrase-1 regulates RBP-mediated mRNA turnover to promote muscle fiber formation
Nucleic Acids Research · 2024
DOI: 10.1093/nar/gkae059 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, 2024. Verfasst von Souad Mubaid und 17 weiteren Autor:innen. Beteiligte Einrichtung: Dept. of Biochemistry, McGill University, 3655 Promenade Sir William Osler, Montreal, QC H3G 1Y6, Canada. Hauptthemen laut MEDLINE: Tankyrases, RNA, Messenger, Muscle Development, Muscle Fibers, Skeletal. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 123 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CIHR, Faculty at Medicine of McGill University, KAUST.
Abstract (Originalsprache)
Poly(ADP-ribosylation) (PARylation) is a post-translational modification mediated by a subset of ADP-ribosyl transferases (ARTs). Although PARylation-inhibition based therapies are considered as an avenue to combat debilitating diseases such as cancer and myopathies, the role of this modification in physiological processes such as cell differentiation remains unclear. Here, we show that Tankyrase1 (TNKS1), a PARylating ART, plays a major role in myogenesis, a vital process known to drive muscle fiber formation and regeneration. Although all bona fide PARPs are expressed in muscle cells, experiments using siRNA-mediated knockdown or pharmacological inhibition show that TNKS1 is the enzyme responsible of catalyzing PARylation during myogenesis. Via this activity, TNKS1 controls the turnover of mRNAs encoding myogenic regulatory factors such as nucleophosmin (NPM) and myogenin. TNKS1 mediates these effects by targeting RNA-binding proteins such as Human Antigen R (HuR). HuR harbors a conserved TNKS-binding motif (TBM), the mutation of which not only prevents the association of HuR with TNKS1 and its PARylation, but also precludes HuR from regulating the turnover of NPM and myogenin mRNAs as well as from promoting myogenesis. Therefore, our data uncover a new role for TNKS1 as a key modulator of RBP-mediated post-transcriptional events required for vital processes such as myogenesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Dept. of Biochemistry, McGill University, 3655 Promenade Sir William Osler, Montreal, QC H3G 1Y6, Canada.
- Rosalind & Morris Goodman Cancer Institute, McGill University, 1160 Pine Avenue, Montreal, QC H3A 1A3, Canada.
- KAUST Smart-Health Initiative (KSHI) and Biological and Environmental Science and Engineering (BESE) Division, King Abdullah University of Science and Technology (KAUST), Jeddah, Saudi Arabia.
- Centre de recherche du CHU de Québec-Pavillon CHUL, Faculté de Médecine, Université Laval, Québec G1V 4G2, Canada.
ORCID-Profile: Kholoud Ashour, Imed-Eddine Gallouzi
Förderung
- CIHR
- Faculty at Medicine of McGill University
- KAUST
Zitieren
APA
Mubaid, S., Sanchez, B. J., Algehani, R. A., Skopenkova, V., Adjibade, P., Hall, D. T., Busque, S., Lian, X. J., Ashour, K., Tremblay, A. K., Carlile, G., Gagné, J. P., Diaz-Gaxiola, A., Khattak, S., Di Marco, S., Thomas, D. Y., Poirier, G. G., & Gallouzi, I. E. (2024). Tankyrase-1 regulates RBP-mediated mRNA turnover to promote muscle fiber formation. Nucleic Acids Research. https://doi.org/10.1093/nar/gkae059
Vancouver
Mubaid S, Sanchez BJ, Algehani RA, Skopenkova V, Adjibade P, Hall DT, et al. Tankyrase-1 regulates RBP-mediated mRNA turnover to promote muscle fiber formation. Nucleic Acids Research. 2024. doi:10.1093/nar/gkae059
BibTeX
@article{Mubaid2024,
author = {Mubaid, Souad and Sanchez, Brenda Janice and Algehani, Rinad A and Skopenkova, Viktoriia and Adjibade, Pauline and Hall, Derek T and Busque, Sandrine and Lian, Xian Jin and Ashour, Kholoud and Tremblay, Anne-Marie K and Carlile, Graeme and Gagné, Jean-Philippe and Diaz-Gaxiola, Andrea and Khattak, Shahryar and Di Marco, Sergio and Thomas, David Y and Poirier, Guy G and Gallouzi, Imed-Eddine},
title = {Tankyrase-1 regulates RBP-mediated mRNA turnover to promote muscle fiber formation},
journal = {Nucleic Acids Research},
year = {2024},
doi = {10.1093/nar/gkae059}
}
EUVIMED